NATURE'S ANSWER, INC. – Trademark Portfolio
Entity Type: 03
NATURE'S ANSWER, INC. holds 57 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 51 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 21 trademarks are registered and 5 are pending. Notable registered marks include KAVA-6, UT ANSWER, KID-B-WELL, QUICK-SORB, and TURMERIC-3. The owner is based in HAUPPAUGE, NY.
75 COMMERCE DRIVE,
HAUPPAUGE, NY 11788
Showing of trademarks Trademarks
Trademark Classifications
NATURE'S ANSWER, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does NATURE'S ANSWER, INC. have?
NATURE'S ANSWER, INC. has 57 U.S. trademarks filed with the USPTO. Of these, 21 registered, 5 pending, 9 abandoned, 22 cancelled.
What trademark classes does NATURE'S ANSWER, INC. file in?
NATURE'S ANSWER, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NATURE'S ANSWER, INC.'s most well-known trademarks?
NATURE'S ANSWER, INC.'s registered trademark portfolio includes well-known marks such as KAVA-6, UT ANSWER, KID-B-WELL, QUICK-SORB, and TURMERIC-3. These are among 21 currently registered trademarks in the portfolio.
What is NATURE'S ANSWER, INC.'s trademark registration success rate?
NATURE'S ANSWER, INC. has a 40% trademark registration rate, with 21 out of 52 resolved applications resulting in successful registration. Currently, 5 applications are pending review.